Adding an experimental mRNA-based vaccine from Moderna Inc <a href="https://www.reuters.com/companies/MRNA.O" target="_blank">(MRNA.O)</a> and Merck & Co <a href="https://www.reuters.com/companies/MRK.N" target="_blank">(MRK.N)</a> reduced the risk that the m…